GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Assets | ₹11,173 Cr | ₹10,611 Cr | ₹8,778 Cr | ₹7,834 Cr | ₹6,496 Cr |
What is the latest Total Assets ratio of GLAND PHARMA ?
| Year | Total Assets |
|---|---|
| Mar2025 | ₹11,173 Cr |
| Mar2024 | ₹10,611 Cr |
| Mar2023 | ₹8,778 Cr |
| Mar2022 | ₹7,834 Cr |
| Mar2021 | ₹6,496 Cr |
How is Total Assets of GLAND PHARMA Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹11,173 Cr | 5.30 | |
| Mar2024 | ₹10,611 Cr | 20.89 | |
| Mar2023 | ₹8,778 Cr | 12.05 | |
| Mar2022 | ₹7,834 Cr | 20.59 | |
| Mar2021 | ₹6,496 Cr | - | |
Compare Total Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹27,520.0 Cr | -2.5% | -8.8% | -5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,220.0 Cr | 1.2% | 2.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,486.0 Cr | 0.9% | -2.5% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,963.0 Cr | 0.5% | -1.5% | 12.3% | Stock Analytics | |
| CIPLA | ₹121,751.0 Cr | 1.1% | -1.6% | 4.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,866.0 Cr | 2.7% | 2.9% | 3.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -2.5% |
-8.8% |
-5.4% |
| SENSEX | 0.1% |
0.9% |
4.5% |
You may also like the below Video Courses